Dr. Anna Lembke on Using GLP-1 Drugs to Treat Addiction
Stanford University psychiatrist, Dr. Anna Lembke, assesses the use of GLP-1 drugs for treating addictions.
The Impact of GLP-1 Drugs on Reward Pathways
We examine the impact of GLP-1 drugs such as Ozempic on reward pathways and the dopamine system.
Move Over Ozempic, Here Comes Petrelintide
Roche has signed a multi-billion dollar deal with Zealand Pharma to develop the weight loss drug petrelintide.
Can GLP-1 Drugs Treat Pornography Addiction?
A look at the scientific evidence on the use of GLP-1 drugs to treat problem sexual behaviors.
Novo Nordisk Walks Back Comments on Addiction Testing
Pharmaceutical giant Novo Nordisk is walking back comments about testing GLP-1 drugs for use in addiction treatment.
Novo Nordisk to Test GLP-1 Drugs Against Addiction
Novo Nordisk, maker of Ozempic and Wegovy, says they will start testing GLP-1 drugs for use in treating addiction.